Private Equity | Behavioral Healthcare Executive Skip to content Skip to navigation

Private Equity

TCIV: Behavioral health demonstrates unique market dynamics

December 5, 2017  |  Julie Miller, Editor in Chief

Healthcare merger and acquisition activity overall has remained steady for the past several years, however, the behavioral health segment has exhibited some unique market dynamics.

5 things to know about follow-on deals

November 13, 2017  |  Julie Miller, Editor in Chief

After an initial platform deal, private equity investors look for secondary, add-on deals that enhance their portfolios by filling gaps and building scale. Here are five things to know about follow-on deals.

State investigation of RCA prompts industry caution

August 31, 2017  |  Julie Miller and Gary Enos, Editors

As a whole, the treatment community remains concerned about the public perception of addiction treatment centers.

University Park start-up aims for niche opportunities

August 14, 2017  |  Julie Miller, Editor in Chief

For new start-up University Park Behavioral Health, a market opportunity lies in the transitional space right after detox, where thorough assessments can proactively ensure better treatment.

CleanSlate portfolio grows with demand for MAT

June 15, 2017  |  Julie Miller, Editor in Chief

CleanSlate's growth is driven by an emerging demand for medication-assisted treatment services as well as market opportunity. With backing from growth-equity fund Apple Tree Partners, the organization is primarily expanding through new center openings.

TCEM: Proving value will be the challenge for the future

May 18, 2017  |  BHE Staff

At the Treatment Center Executive and Marketing Retreat, CEO Doug Tieman recommended that today’s treatment centers begin by prioritizing their revenue path and expansion strategies.

Ethics Survey: Drug testing remains a clinical tug of war

May 18, 2017  |  Julie Miller, Editor in Chief

Treatment centers must weigh costs and clinical needs when creating policies for patient drug testing. Meanwhile, investors are examining how drug testing fits in the greater scheme of profits and regulatory risks.

10 ways private equity investors evaluate addiction treatment centers

February 13, 2017  |  Ron Lebow and Kelly M. Hagemann

The first priority for an equity investor is to perform the diligence necessary to uncover problem areas and ensure a return on investment.

REIT transactions offer treatment centers source of capital

December 14, 2016  |  Julie Miller, Editor in Chief

The benefit of selling to a REIT is that the deal unlocks the equity that’s been built up in the treatment center's real estate.

CEO says providers can thrive if they heed history

September 28, 2016  |  Gary Enos, Editor

A keynote at the Moments of Change conference offered a prominent addiction field leader's advice to study history and not repeat mistakes of the past.

Follow the money in behavioral healthcare

August 30, 2016  |  Ed Jones, PhD

Private equity investors are putting a great deal of time, effort and money into figuring out how to transform the behavioral healthcare industry, and our industry leaders must match that, in terms of time and effort, if not money.

N.J. treatment center employees make rare move to unionize

July 26, 2016  |  Julie Miller, Editor in Chief

More than 100 clinical and non-clinical employees at Sunrise House have voted to unionize, but experts say unions are unlikely to become widespread.


Subscribe to Private Equity